How to stratify patients at risk for resistant bugs in skin and soft tissue infections?

Current Opinion in Infectious Diseases

Volumn 29, Issue 2, 2016, Pages 116-123

  Guillamet, Cristina Vazquez ^a,b   Kollef, Marin H ^c  

^a Critical Care and Sleep Medicine   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Patient outcomes; Skin and soft tissue infections

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIAL SKIN DISEASE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; RISK ASSESSMENT; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; ACINETOBACTER; BACTERIUM; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ACINETOBACTER; BACTERIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTORS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84960114363     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000244     Document Type: Review

References (74)

1. Hersh AL. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008;168:1585.
2. Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009;15:1516-1518.
3. Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of methicillinresistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005;45:311-320.
4. Ellis Simonsen SM, van Orman ER, Hatch BE, et al. Cellulitis incidence in a defined population. Epidemiol Infect 2006;134:293-299.
5. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 2014;59:147-159. A concise update for clinicians highlighting recommendations for the treatment of SSTIs.
6. Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008;51:291-298.
7. Stenstrom R, Grafstein E, Romney M, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. CJEM 2009;11:430-438.
8. Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system. JAMA 2012;308:50-59.
9. Jenkins TC, Sabel AL, Sarcone EE, et al. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clin Infect Dis Off Publ Infect Dis Soc Am 2010;51:895-903.
10. Talan DA, Krishnadasan A, Gorwitz RJ, et al., EMERGEncy ID Net Study Group. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis Off Publ Infect Dis Soc Am 2011;53:144-149.
11. Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U. S.population: a retrospective population-based study. BMC Infect Dis 2013;13:252.
12. Moet GJ, Jones RN, Biedenbach DJ, et al. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2007;57:7-13.
13. Djahmi N, Messad N, Nedjai S, et al. Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2013;19:E398-E404.
14. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis Off Publ Infect Dis Soc Am 2012;54:e132-e173.
15. Corey GR, Wilcox M, Talbot GH, et al. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis Off Publ Infect Dis Soc Am 2010;51:641-650.
16. BoucherHW, WilcoxM, Talbot GH, etal. Once-weeklydalbavancinversusdaily conventional therapy for skin infection. N Engl J Med 2014;370:2169-2179. Describes a once weekly therapy for the treatment of SSTIs primarily attributed to MRSA.
17. Prokocimer P, De Anda C, Fang E, et al. Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTAB-LISH-1 randomized trial. JAMA 2013;309:559-569.
18. Han LL, McDougal LK, Gorwitz RJ, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsedfield type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol 2007;45:1350-1352.
19. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148:249-257.
20. Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007;51:423-428.
21. Liu C, Graber CJ, Karr M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco. Clin Infect Dis Off Publ Infect Dis Soc Am 2008;46:1637-1646.
22. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S.aureus infection: a prospective investigation. Clin Infect Dis Off Publ Infect Dis Soc Am 2007;44:471-482.
23. D'Agata EMC, Webb GF, Horn MA, et al. Modeling the invasionofcommunityacquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis Off Publ Infect Dis Soc Am 2009;48:274-284.
24. Centers for Disease Control and Prevention (CDC). Invasive methicillinresistant Staphylococcus aureus infections among dialysis patients: United States. MMWR Morb Mortal Wkly Rep 2007;56:197-199.
25. Mathews WC, Caperna JC, Barber RE, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005;1999:2005;40:155-160.
26. Skiest DJ, Brown K, Cooper TW, et al. Prospective comparison of methicillinsusceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 2007;54:427-434.
27. Albrecht VS, Limbago BM, Moran GJ, et al. Staphylococcus aureus colonization and strain type at various body sites among patients with a closed abscess and uninfected controls at U. S.emergency departments. J Clin Microbiol 2015;53:3478-3484. Describes the relationship between prior colonization with S. aureus and subsequent development of cutaneous abscesses.
28. Yang ES, Tan J, Eells S, et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S.aureus skin infections. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2010;16:425-431.
29. Gibson KE, McNamara SE, Cassone M, et al., Targeted Infection Prevention Study Team, Ann Arbor, Michigan. Methicillin-resistant Staphylococcus aureus: site of acquisition and strain variation in high-risk nursing home residents with indwelling devices. Infect Control Hosp Epidemiol 2014;35:1458-1465.
30. Kumar N, David MZ, Boyle-Vavra S, et al. High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department. J Clin Microbiol 2015;53:810-815. A study providing evidence that colonization with specific clones of MRSA may predispose to subsequent SSTIs.
31. Weintrob A, Bebu I, Agan B, et al. Randomized, double-blind, placebo-controlled study on decolonization procedures for methicillin-resistant Staphylococcus aureus (MRSA) among HIV-infected adults. PloS One 2015;10:e0128071. A 1-week decolonization procedure had no effect on MRSA colonization at the 6-month time point or subsequent infection rates among community-dwelling HIV-infected persons.
32. Ellis MW, Schlett CD, Millar EV, et al. Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft tissue infections: a cluster-randomized controlled trial among high-risk military trainees. Clin Infect Dis Off Publ Infect Dis Soc Am 2014;58:1540-1548. Personal hygiene and education measures, including once-weekly use of chlorhexidine body wash, did not prevent overall SSTI or MRSA SSTI in a high-risk population of military trainees.
33. Millar EV, Chen W-J, Schlett CD, et al. Frequent use of chlorhexidine-based body wash associated with a reduction in methicillin-resistant Staphylococcus aureus nasal colonization among military trainees. Antimicrob Agents Chemother 2015;59:943-949. Frequent use of chlorhexidine body wash was associated with a modest reduction in MRSA nasal colonization in military trainees.
34. Whitman TJ, Herlihy RK, Schlett CD, et al. Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial. Infect Control Hosp Epidemiol 2010;31:1207-1215.
35. Shenoy ES, Paras ML, Noubary F, et al. Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): asystematic review. BMC Infect Dis 2014;14:177.
36. HemmigeV, McNulty M, Silverman E, David MZ. Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study. BMC Infect Dis 2015;15:455.
37. Hemmige V, McNulty M, Silverman E, David MZ. Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 2015;34:339-347. HIV-infected individuals are at high risk for SSTIs. In a primarily urban, African-American cohort, immunologic and demographic factors were most often associated with the development of SSTIs.
38. Crum-Cianflone NF, Wang X, Weintrob A, et al. Specific behaviors predict Staphylococcus aureus colonization and skin and soft tissue infections among human immunodeficiency virus-infected persons. Open Forum Infect Dis 2015;2:ofv034.
39. Kuo DC, Chasm RM, Witting MD. Emergency physician ability to predict methicillin-resistant Staphylococcus aureus skin and soft tissue infections. J Emerg Med 2010;39:17-20.
40. Miller LG, Daum RS, Creech CB, et al., DMID 07-0051 Team. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med 2015;372:1093-1103. In a randomized trial, no significant difference was found between clindamycin and trimethoprim-sulfamethoxazole, with respect to either efficacy or side-effect profile, for the treatment of uncomplicated SSTIs.
41. Marin JR, Bilker W, Lautenbach E, Alpern ER. Reliability of clinical examinations for pediatric skin and soft-tissue infections. Pediatrics 2010;126:925-930.
42. Uçkay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab 2014;16:305-316. A review on the causes of infection and treatment for DFI.
43. Ozkurt Z, Ertek M, Erol S, et al. The risk factors for acquisition of imipenemresistant Pseudomonas aeruginosa in the burn unit. Burns J Int Soc Burn Inj 2005;31:870-873.
44. Ranjbar R, Owlia P, Saderi H, et al. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran. Acta Med Iran 2011;49:675-679.
45. Lipsky BA, Kollef MH, Miller LG, et al. Predicting bacteremia among patients hospitalized for skin and skin-structure infections: derivation and validation of a risk score. Infect Control Hosp Epidemiol 2010;31:828-837.
46. Tascini C, Lipsky BA, Iacopi E, et al. KPC-producing Klebsiella pneumoniae rectal colonization is a risk factor for mortality in patients with diabetic foot infections. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2015;21:790. A clinical study demonstrating that in patients with DFI, K. pneumoniae carbapenemase gut colonization appears to be an important risk factor for mortality.
47. Meyer E, Schwab F, Gastmeier P, et al. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). J Hosp Infect 2006;64:238-243.
48. Ansari SR, Hanna H, Hachem R, et al. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 2007;109:2615-2622.
49. El Amari EB, Chamot E, Auckenthaler R, et al. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis Off Publ Infect Dis Soc Am 2001;33:1859-1864.
50. Lepper PM, Grusa E, Reichl H, et al. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002;46:2920-2925.
51. López-Dupla M, Martínez J-A, Vidal F, et al. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates. Am J Infect Control 2009;37:753-758.
52. Cobos-Trigueros N, Solé M, Castro P, et al. Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure. Crit Care Lond Engl 2015;19:218. A clinical study highlighting the risk factors for P. aeruginosa acquisition and infection in the ICU setting.
53. Schneider-Lindner V, Delaney JA, Dial S, et al. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis 2007;13:994-1000.
54. 2014 National Burn Repository Annual Report. Report of Data From 2004-2013. http://www.ameriburn.org/2014NBRAnnualReport.pdf. [Accessed 25 October 2015]
55. Altoparlak U, Aktas F, Celebi D, et al. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates. Burns J Int Soc Burn Inj 2005;31:707-710.
56. Horvath EE, Murray CK, Vaughan GM, et al. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg 2007;245:978-985.
57. Murray CK, Loo FL, Hospenthal DR, et al. Incidence of systemic fungal infection and related mortality following severe burns. Burns J Int Soc Burn Inj 2008;34:1108-1112.
58. Saaiq M, Ahmad S, Zaib MS. Burn wound infections and antibiotic susceptibility patterns at Pakistan Institute of Medical Sciences, Islamabad, Pakistan. World J Plast Surg 2015;4:9-15.
59. Agnihotri N, Gupta V, Joshi RM. Aerobic bacterial isolates from burn wound infections and their antibiograms: a five-year study. Burns J Int Soc Burn Inj 2004;30:241-243.
60. Albrecht MC, Albrecht MA, Griffith ME, et al. Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg 2006;203:546-550.
61. Schweizer ML, Chiang H-Y, Septimus E, et al. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA 2015;313:2162-2171. A multicenter study demonstrating that a prevention bundle comprising S. aureus screening, decolonization, and targeted prophylaxis was associated with a modest, statistically significant decrease in complex SSTIs due to S. aureus.
62. Johnson AT, Nygaard RM, Cohen EM, et al. The impact of hospital-acquired methicillin-resistant Staphylococcus aureus in a burn population after implementation of universal decolonization protocol. J Burn Care Res Off Publ Am Burn Assoc 2015. [Epub ahead of print] A single-center study demonstrating that the prevalence of HA-MRSA at the institution's burn center was significantly decreased after the implementation of a universal decolonization protocol.
63. Vaiman M, Lazarovitch T, Heller L, Lotan G. Ecthyma gangrenosum and ecthyma-like lesions: review article. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 2015;34:633-639. A nice review on the cause of ecthyma gangrenosum.
64. Saltoglu N, Yemisen M, Ergonul O, et al. Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2015;21:659-664. In a multivariate analysis, the presence of Gram-negative rod in addition to more classic risk factors (male sex, duration of diabetes >20 years, infected ulcers, history of peripheral vascular disease, and retinopathy) was a significant predictor of limb loss.
65. Unal S, Ersoz G, Demirkan F, et al. Analysis of skin-graft loss due to infection: infection-related graft loss. Ann Plast Surg 2005;55:102-106.
66. Nonaka Y, Nagae M, Omae T, et al. Community-acquired necrotizing fasciitis caused by Acinetobacter calcoaceticus: a case report and literature review. J Infect Chemother Off J Jpn Soc Chemother 2014;20:330-335. A case report highlighting the capability of Acinetobacter species to cause community-acquired SSTIs.
67. Sinha N, Niazi M, Lvovsky D. A fatal case of multidrug resistant acinetobacter necrotizing fasciitis: the changing scary face of nosocomial infection. Case Rep Infect Dis 2014;2014:705279.
68. Ali A, Botha J, Tiruvoipati R. Fatal skin and soft tissue infection of multidrug resistant Acinetobacter baumannii: a case report. Int J Surg Case Rep 2014;5:532-536.
69. Roriz M, Maruani A, Le Bidre E, et al. Locoregional multiple nodular panniculitis induced by Pseudomonas aeruginosa without septicemia: three cases and focus on predisposing factors. JAMA Dermatol 2014;150:628-632.
70. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-1453.
71. Kimura AC, Higa JI, Levin RM, et al. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis Off Publ Infect Dis Soc Am 2004;38:e87-e91.
72. McGuigan CC, Penrice GM, Gruer L, et al. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol 2002;51:971-977.
73. Burman WJ, Cohn DL, Reves RR, Wilson ML. Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin Infect Dis Off Publ Infect Dis Soc Am 1995;20:564-570.
74. Sullivan AK, Nelson MR, Walsh J, Gazzard BG. Recurrent Helicobacter cinaedi cellulitis and bacteraemia in a patient with HIV Infection. Int J STD AIDS 1997;8:59-60.